Cell cycle activation in AD was confirmed at the protein and tissue levels, and was suppressed by rapamycin, indicating the importance of the rapamycin-sensitive mTOR pathway in cell cycle activation in AD. This evidence concerns the gene MTOR and Alzheimer disease.